Key result
Among anti-inflammatory strategies for cardiac surgery, only leukocyte filters significantly reduced the incidence of worsening renal function compared to control (1.1% vs. 7.5%; OR 0.18; 95% CI 0.05-0.64; P=0.008).
Why the study?
Do anti-inflammatory strategies (glucocorticoids, MECC, or leukocyte filters) reduce postoperative acute kidney injury in patients undergoing cardiac surgery?
Population
2,252 adult patients undergoing cardiac surgery across 29 RCTs.
Comparison
Anti-inflammatory strategies during… vs Placebo or standard cardiopulmonary bypass…
Design
Meta-analysis
Follow-up
postoperative
Authors
Loading...
May reduce postop AKI; extends RCT evidence on inflammation modulation in cardiac surgery.
Meta-Analysis (n=2,252)
Do anti-inflammatory strategies (glucocorticoids, MECC, or leukocyte filters) reduce postoperative acute kidney injury in patients undergoing cardiac surgery?
Odds Ratio: 0.18 (95% CI 0.05–0.64)
Absolute Event Rate: 1.1% vs 7.5%
p-value: p=0.008
Among cardiopulmonary bypass-related anti-inflammatory strategies, only leukocyte filters significantly reduced the incidence of postoperative acute kidney injury in cardiac surgery patients.
Scrascia et al. (2013) conducted a meta-analysis in Acute kidney injury (AKI) after cardiac operations (n=2,252). Anti-inflammatory strategies (leukocyte filters, steroids, MECC) vs. Placebo or standard care was evaluated on Worsening renal function (WRF) (OR 0.18, 95% CI 0.05-0.64, p=0.008). Among anti-inflammatory strategies for cardiac surgery, only leukocyte filters significantly reduced the incidence of worsening renal function compared to control (1.1% vs. 7.5%; OR 0.18; 95% CI 0.05-0.64; P=0.008).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: